AZGP1 and colorectal carcinoma: In accordance with our results, Ji et al. reported that serum ZAG was a useful biomarker for CRC within ROC curve areas of 0.9572 (95% CI 0.9173–0.9971) in a cohort of 534 Chinese individuals (27).